| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
27,030,000 |
| Market
Cap: |
122.99(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.68 - $13.05 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile VistaGen Therapeutics is a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company engaging in the treatment for individuals living with anxiety, depression and other CNS disorders. Co.'s product candidates include: PH94B, which is a synthetic investigational pherine nasal spray with a mechanism of action (MOA) that regulates the olfactory-amygdala neural circuits of fear and anxiety and attenuates the tone of the sympathetic autonomic nervous system; and PH10, which is a synthetic investigational pherine nasal spray with a rapid-onset potential MOA that is fundamentally differentiated from the MOA of existing approved treatments for depression disorders.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
775,756 |
1,875,756 |
| Total Buy Value |
$0 |
$0 |
$17,961,079 |
$18,150,929 |
| Total People Bought |
0 |
0 |
1 |
4 |
| Total Buy Transactions |
0 |
0 |
1 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
60,000 |
| Total Sell Value |
$0 |
$0 |
$0 |
$53,400 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2013-10-15 |
4 |
OE |
$0.64 |
$6,400 |
I/I |
10,000 |
312,174 |
|
- |
|
| Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2013-06-27 |
4 |
OE |
$0.64 |
$32,000 |
I/I |
50,000 |
302,174 |
|
- |
|
| Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2012-12-06 |
4 |
A |
$0.50 |
$50,000 |
I/I |
100,000 |
252,174 |
|
- |
|
| Rice A. Franklin |
VP CORPORATE DEVELOPMENT |
• – – |
2012-05-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
174,046 |
|
- |
|
| Rice A. Franklin |
CHIEF OPERATING OFFICER |
• – – |
2011-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,000 |
224,046 |
|
- |
|
| Platinum Long Term Growth Vii, Llc |
10% Owner |
– – • |
2011-12-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(484,000) |
1,558,862 |
|
- |
|
| Snodgrass H. Ralph |
PRES./CHIEF SCIENTIFIC OFFICER |
• • – |
2011-12-20 |
4 |
OE |
$0.88 |
$100,000 |
D/D |
113,636 |
1,204,468 |
|
- |
|
| Cato Holding Co |
10% Owner |
– – • |
2011-12-15 |
4 |
OE |
$1.11 |
$471,727 |
D/D |
424,124 |
3,310,836 |
|
- |
|
| Saxe Jon S |
|
– • – |
2011-12-14 |
4 |
OE |
$1.25 |
$3,480 |
D/D |
2,784 |
20,138 |
|
- |
|
| Rice A. Franklin |
CHIEF OPERATING OFFICER |
• – – |
2011-08-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
219,000 |
240,046 |
|
- |
|
| Platinum Long Term Growth Vii, Llc |
10% Owner |
– – • |
2011-05-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,042,862 |
|
- |
|
| Cato Holding Co |
10% Owner |
– – • |
2011-05-11 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,448,694 |
|
- |
|
| Cato Allen Easley |
10% Owner |
– – • |
2011-05-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,448,694 |
|
- |
|
| Cato Allen Easley |
10% Owner |
– – • |
2011-05-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,596 |
|
- |
|
| Rice A. Franklin |
CHIEF FINANCIAL OFFICER |
• – – |
2011-05-11 |
4 |
A |
$3.50 |
$803,324 |
D/D |
229,521 |
229,521 |
|
- |
|
| Saxe Jon S |
|
– • – |
2011-05-11 |
4 |
A |
$3.50 |
$60,739 |
D/D |
17,354 |
17,354 |
|
- |
|
| Singh Shawn |
CHIEF EXECUTIVE OFFICER |
• • – |
2011-05-11 |
4 |
A |
$3.50 |
$266,305 |
I/I |
76,087 |
76,087 |
|
- |
|
| Snodgrass H. Ralph |
PRES./CHIEF SCIENTIFIC OFFICER |
• – – |
2011-05-11 |
4 |
A |
$3.50 |
$1,908,956 |
D/D |
545,416 |
545,416 |
|
- |
|
| Jones Stephanie |
PRESIDENT |
• • • |
2011-05-09 |
4 |
S |
$0.00 |
$0 |
D/D |
(4,982,103) |
17,897 |
|
- |
|
| Cato Holding Co |
10% Owner |
– – • |
2011-03-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,457,290 |
|
- |
|
70 Records found
|
|
Page 3 of 3 |
|
|
0.04 (0.87%) 
